Cytochrome 4Z1 Expression is Associated with Poor Prognosis in Colon Cancer Patients.

Area of Science:

• Oncology
• Biochemistry

Background:

• Colon cancer presents a significant global mortality challenge with a poor prognosis, necessitating innovative therapeutic strategies.
• Cytochrome P450 Family 4 Subfamily Z Member 1 (CYP4Z1) is a tumor-associated enzyme of growing interest.
• CYP4Z1's expression in various tumors suggests its potential as a biomarker or therapeutic target for cancer treatment.

Purpose of the Study:

• To investigate the expression patterns of CYP4Z1 in diverse colon tissue types.
• To evaluate the correlation between CYP4Z1 expression and clinicopathological features of colon cancer.
• To assess the prognostic significance of CYP4Z1 in colon cancer patient survival.

Main Methods:

• Immunohistochemical analysis was employed to examine CYP4Z1 overexpression.
• A comprehensive panel of colon tissues, including normal, benign, primary, and metastatic samples, was analyzed.
• Statistical methods were used to correlate CYP4Z1 expression with histopathological characteristics and patient survival outcomes.

Main Results:

• CYP4Z1 was significantly overexpressed in benign, primary, and metastatic colon tissues relative to normal tissues.
• Expression levels of CYP4Z1 were notably higher in metastatic tissues, followed by primary and benign tissues (p < 0.05).
• Elevated CYP4Z1 expression correlated with advanced histological grades, later disease stages, and lymph node metastasis (p < 0.05).
• CYP4Z1 expression emerged as an independent predictor of poor overall survival in colon cancer patients (p = 0.003).

Conclusions:

• CYP4Z1 demonstrates distinct overexpression in benign, primary, and metastatic colon tissues compared to normal counterparts.
• The differential expression of CYP4Z1 across colon tissue types underscores its potential as a valuable biomarker for colon cancer.
• CYP4Z1 represents a promising molecular target for the development of novel anticancer therapies for colon cancer.